Permanent [tmco]
Alteration [idcn]
proprotein convertase subtilisin/kexin type 9 [gngm]
In Vivo [spco]
Genome [gngm]
editing [ocac]
Rationale [idcn]
Loss [qnco]
function [phsf]
proprotein convertase subtilisin/kexin type 9 [gngm]
Mutations [genf]
experience [menp]
Reduced [qlco]
Low density lipoprotein cholesterol level [lbpr]
Protection [fndg]
Cardiovascular disease [dsyn]
Objective [inpr]
Goal [inpr]
Study [mnob]
Genome [gngm]
editing [ocac]
System [ftcn]
introduce [ftcn]
Loss [qnco]
function [phsf]
Mutations [genf]
Endogenous [ftcn]
Proprotein convertase subtilisin/kexin type 9 gene [gngm]
In Vivo [spco]
Methods [inpr]
adenovirus [virs]
Guide [prog]
RNA [nnon]
Targeting [ftcn]
PCSK9 [gngm]
Mouse Liver [tisu]
Gene [gngm]
4 Days [tmco]
Administration [ocac]
Mutagenesis [moft]
PCSK9 [gngm]
Decreased [qnco]
Plasma [bdsu]
proprotein convertase subtilisin/kexin type 9 [gngm]
Levels [qlco]
Increased [qnco]
Hepatic [blor]
Low Density Lipoprotein Receptor [aapp, rcpt]
Levels [qlco]
Decreased [qnco]
plasma cholesterol [lbpr]
Off [qlco]
Target [ftcn]
Mutagenesis [moft]
Detected [fndg]
Select [acty]
Sites [spco]
Conclusions [idcn]
Genome [gngm]
editing [ocac]
System [ftcn]
disrupt [qlco]
PCSK9 gene [gngm]
In Vivo [spco]
Efficiency [qnco]
blood cholesterol [lbpr]
mice [mamm]
Approach [spco]
Therapeutic [topp]
Prevention [topp]
Cardiovascular disease [dsyn]
Humans [humn]
